Language selection

Search

Patent 1244020 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 1244020
(21) Application Number: 435456
(54) English Title: BASIC ESTERS OF BENZOIC ACIDS AND 2-THIO- PHENCARBOXYLIC ACIDS, PROCESSES FOR THEIR PREPARATION AND A PHARMACOLOGICAL COMPOSITION CONTAINING THESE ESTERS
(54) French Title: ESTERS BASIQUES D'ACIDES BENZOIQUES ET D'ACIDES 2-THIOPHENCARBOXYLIQUES; PREPARATION, ET COMPOSITION PHARMACEUTIQUE RENFERMANT CES ESTERS
Status: Expired
Bibliographic Data
(52) Canadian Patent Classification (CPC):
  • 260/474
  • 260/279.25
  • 260/247.26
  • 260/329.3
  • 260/293.6
(51) International Patent Classification (IPC):
  • C07D 333/38 (2006.01)
  • C07D 295/088 (2006.01)
  • C07D 295/14 (2006.01)
(72) Inventors :
  • RUDINGER, EDITH (Switzerland)
  • PERLIA, XAVIER (Switzerland)
(73) Owners :
  • PHARMATON S.A. (Not Available)
(71) Applicants :
(74) Agent: MARKS & CLERK
(74) Associate agent:
(45) Issued: 1988-11-01
(22) Filed Date: 1983-08-26
Availability of licence: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data:
Application No. Country/Territory Date
5115/82-6 Switzerland 1982-08-27

Abstracts

English Abstract


ABSTRACT OF THE DISCLOSURE
The present invention provides novel basic esters of
the formula I

Image (1)

wherein R is a group of the formulae
Image
or
Image

wherein R1 is hydrogen or C1-C4 alkyl, and R2 is C1-C4 alkyl,
halogen, a C1-C4 alkoxy, C1-C4 alkylthio, nitro, amino or a C1-C4
alkylamino, R1 and R2 being the same or different, and R3 is a
basic group selected from di(C1-C4)alkylamino or a 6-membered
nitrogen containing aromatic heterocyclic group which may contain
a further oxygen atom and to their pharmacologically useful salts
with acids which are preferably used in local anaesthesia.



Claims

Note: Claims are shown in the official language in which they were submitted.


THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:

1. A process for preparing a basic ester of formula I

Image (I)

wherein R is a group of the formulae

Image
or
Image
wherein R1 is hydrogen or C1-C4 alkyl, and R2 is C1-C4 alkyl,
halogen, a C1-C4 alkoxy, C1-C4 alkylthio, nitro, amino or a C1-C4
alkylamino, R1 and R2 being the same or different, and R3 is a
basic group selected from di(C1-C4) alkylamino or a 6-membered
nitrogen containing aromatic heterocyclic group which may contain
a further oxygen atom or a pharmacoloyically useful salt thereof
with an acid in which (a) a benzoic acid or a thiophencarboxylic
acid or an acid halide thereof of the formula


Image or Image


wherein R' is a hydroxyl group or halogen, and R1 and R2 are as

12

above, are reacted with an alcohol of formula II
HO-CH -CH2-R3 (II)

wherein R3 is as above, or (b) a salt of a benzoic acid or a
thiophencarboxylic acid of the formulae

Image or Image

wherein M is a metal atom, and R1 and R2 are defined above, is
reacted with a halide of formula III

Hal-CH2-CH2-R3

wherein Hal is a halogen atom, and R3 is defined above and when
required the free base obtained is converted into a pharmacolo-
gically useful salt with an acid.

2. The process of claim 1, in which the acid halide in
(a) is an acid chloride.

3. The process of claim 1, in which the halide of
formula III is a chloride.

4. The process according to claim 1 or 3, in which the
salt of the benzoic acid or the thiophencarboxylic acid is an
alkali metal salt.

5. A basic ester of the formula I

13


Image (I)

wherein R is a group of the formulae
Image
or
Image

wherein R1 is hydrogen or C1-C4 alkyl, and R2 is C1-C4 alkyl,
halogen, a C1-C4 alkoxy, C1-C4 alkylthio, nitro, amino or a C1-C4
alkylamino, R1 and R2 being the same or different, and R3 is a
basic group selected from di(C1-C4) alkylamino or a 6-membered
nitrogen containing aromatic heterocyclic group which may contain
a further oxygen atom or a pharmacologically useful salt thereof.

6. A process according to claim 1, in which R1 is
hydrogen or methyl, R2 is methyl, fluorine, bromine, iodine,
ethoxy, ethylthio, nitro, amino, ethylamino, or butylamino, and
R3 is diethylamino, piperidino or morpholino.

7. A compound of formula I given in claim 1 or a
pharmacologically useful salt thereof with an acid in which R1,
R2 and R3 are as in claim 6.

8. A process according to claim 6, in which R is a
group of the formula

Image

14

wherein R1 and R2 are as in claim 6.

9. A compound of formula I given in claim 1 or a
pharmacologically useful salt thereof with an acid In which R is
as in claim 8 and R1, R2 and R3 are as in claim 8.

10. A process according to claim 6, in which R is a
group of the formula

Image

wherein R1 is as in claim 6.

11. A compound of formula I given in claim 1 or a
pharmacologically useful salt thereof with an acid in which R is
as in claim 10 and R1 and R3 are as in claim 6.

12. A process according to claim 1, in which the free
base is reacted with an acid selected from hydrochloric, hydro-
bromic, fumaric or maleic acid.

13. A salt of a basic ester of the formula I given in
claim 1, wherein R and R3 are as in claim 1 which is a hydro-
chloride, hydrobromide, fumarate, maleate, hydrogenfumarate or
hydrogenmaleate.

14. A process according to claim 1, in which R is

Image

wherein R1 Is hydrogen and R2 is methyl and R3 is piperldino.

15. A process according to claim 1, which comprises
reacting 2-methylbenzoic in an ethanolic sodium methylate



solution with N-(2-chloroethyl)-piperldine.

16. 2-methylbenzoic acid-2-piperldino ethyl ester or a
pharmaceutically acceptable acid addition salt thereof.

17. A process according to claim 1, In which R is

Image

wherein R1 and R2 are methyl and R3 is piperldino.

18. A process according to claim 1, which comprises
reacting 2,6-dimethylbenzoic acid in an ethanolic sodium methy-
late solution with N-(2-chloroethyl)-piperldine.

19. 2,6-dimethylbenzoic acid-2-piperldino-ethyl ester
or a pharmaceutically acceptable acid addition salt thereof.

20. A process according to claim 1, In which R Is
Image
wherein R1 is methyl, R2 is fluoro and R3 is diethylamino.

21. A process according to claim 1, which comprises
reacting 2-fluoro-6-methylbenzoic acid in an ethanolic sodium
ethylate solution with 2-diethylamino-ethylchloride.

22. 2-fluoro-6-methylbenzoic acid-2-diethylaminoethyl
ester or a pharmaceutically acceptable acid addition salt there-
of.

23. A process according to claim 1, in which R is

Image

16

wherein R1 is methyl, R2 is bromo and R3 is diethylamino.

24. A process according to claim 1, which comprises
reacting 2-bromo-6-methyl-benzoic acid in an ethanolic sodium
methylate solution with 2-diethylamino-ethylchloride.

25. 2-bromo-6-methylbenzoic acid-2-diethylamino ethyl
ester or a pharmaceutically acceptable acid addition salt there-
of.

26. A process according to claim 1, In which R is
Image

wherein R1 is methyl, R2 is lodo and R3 is diethylamino.,

27. A process according to claim 1, which comprises
reacting 2-lodo-6-methylbenzoic acid in ethanolic sodium methy-
late solution with 2-diethylamino-ethylchloride.

28. 2-lodo-6-methylbenzoic acid-2-diethylamino-ethyl
ester or a pharmaceutically acceptable acid addition salt there-
of.

29. A process according to claim 1, In which R is
Image

wherein R1 is methyl, R2 is ethoxy and R3 is diethylamino.

30. A process according to claim 1, which comprises
reacting 2-ethoxy-6-methylbenzoic acid in an ethanolic sodium
methylate solution with 2-diethylamino-ethylchloride.

31. 2-ethoxy-6-methylbenzoic acid-2-diethylamino-ethyl
ester or a pharmaceutically acceptable acid addition salt there-

17


of.

32. A process according to claim 1, in which R Is
Image
wherein R1 is methyl, R2 is ethoxy and R3 is piperldino.

33. A process according to claim 1, which comprises
reacting 2-ethoxy-6-methylbenzoic acid in an ethanolic sodium
methylate solution with 2-ethoxy-6-methyibenzoic acid-2-piper-
idino-ethyl ester.

34. 2-ethoxy-6-methylbenzoic acid-2-piperldino-ethyl
ester or a pharmaceutically acceptable acid addition salt there-
of.

35. A process according to claim 1, in which R is
Image

wherein R1 is methyl, R2 is ethylthio and R3 is diethylamino.

36. A process according to claim 1, which comprises
reacting 2-ethylthio-6-methylbenzoic acid in an ethanolic sodium
methylate with 2-diethylamino-ethylchloride.

37. 2-ethylthio-6-methylbenzoic acid-2-diethylamino-
ethyl ester or a pharmaceutically acceptable acid addition salt
thereof.

38. A process according to claim 1, in which R is
Image

wherein R1 is methyl, R2 is nitro and R3 is diethylamino.

18

39. A process according to claim 1, which comprises
reacting 2-methyl-6-nitrobenzoic acid in an ethanolic sodium
methylate solution with 2-diethylamino-ethylchloride.

40. 2-methyl-6-nitrobenzoic acid-2-diethylamino-ethyl
ester or a pharmaceutically acceptable acid addition salt there-
of.

41. A process according to claim 1, In which R Is
Image
wherein R1 is methyl, R2 is nitro and R3 is piperldino.

42. A process according to claim 1, which comprises
reacting 2-methyl-6-nitrobenzoic acid in an ethanolic sodium
methylate solution with N-(2-chloroethyl)-piperldine.

43. 2-methyl-6-nitrobenzoic acid-2-piperldino-ethyl
ester or a pharmaceutically acceptable acid addition salt there-
of,

44. A process according to claim 1, in which R is
Image
wherein R1 is methyl, R2 is nitro and R3 is morpholino.

45. A process according to claim 1, which comprises
reacting 2-methylbenzoic acid in an ethanolic sodium methylate
solution with 4-(2-chloroethyl)-morpholine.

46. 2-methyl-6-nitrobenzoic acid-2-moropholino ethyl
ester or a pharmaceutically acceptable acid addition salt there-
of.

19

47. A process according to claim 1, in which R is
Image
wherein R1 is methyl, R2 is ethylamino and R3 is diethylamino.

48. A process according to claim 1, which comprises
reacting 2-ethylamino-6-methylbenzoic acid in an ethanolic sodium
methylate solution with 2-diethylamino-ethylchoride.

49. 2-ethylamino-6-methylbenzoic acid-2-diethylamino-
ethyl ester or a pharmaceutically acceptable acid addition salt
thereof.

50. A process according to claim 1, in which R is

Image

wherein R1 is methyl, R2 is butylamino and R3 is diethylamino.

51. A process according to claim 1, which comprises
reacting 2-butylamino-6-methylbenzoic acid in an ethanolic sodium
methylate solution with 2-diethylamino-ethylchloride.

52. 2-butylamino-6-methylbenzoic acid-2-diethylamino-
ethyl ester or a pharmaceutically acceptable acid addition salt
thereof.

53. A process according to claim 1, in which R is
Image

wherein R1 is methyl, R2 is amino and R3 is diethylamino.

54. A process which comprises heating 2-methyl-6-
nitrobenzoic acid-2-diethylamino-ethyl ester in concentrated



hydrochloric acid with tin(II)-chloride.

55. 2-amino-6-methylbenzoic acid-2-diethylamino-ethyl-
ester or a pharmaceutically acceptable acid addition salt there-
of.

56. A process according to claim 1, in which R is
Image

wherein R1 is methyl, R2 is amino and R3 is piperldino.

57. A process which comprises heating 2-methyl-6-
nitrobenzoic acid-N-(2-piperldino)-ethyl ester in concentrated
hydrochloric acid with tint(II)-chloride.

58. 2-amino-6-methylbenzoic acid-N-(2-piperldino)-ethyl
ester or a pharmaceutically acceptable acid addition salt there-
of.

59. A process according to claim 1, in which R is
Image
wherein R1 is methyl in the 3-position and hydrogen in the 5-
position.

60. A process according to claim 1, which comprises
reacting 3-methylthiophen-2-carboxylic acid in an ethanolic
sodium methylate solution with 2-diethylamino-ethylchloride.

61. 3-methylthiophen-2-carboxylic acid-2-diethylamino-
ethyl ester or a pharmaceutically acceptable acid addition salt
thereof.


21

62. A process according to claim 1, in which R is
Image
wherein R1 is methyl un the 5-position and R1 is hydrogen in the
3-position.

63. A process according to claim 1, which comprises
reacting 5-methylthiophen-2-carboxylic acid in an ethanolic
sodium solution with 2-diethylamino-ethylchloride.

64. 5-methylthiophen-2-carboxylic acid-2-diethylamino-
ethyl ester or a pharmaceutically acceptable acid addition salt
thereof.

22

Description

Note: Descriptions are shown in the official language in which they were submitted.


The present invention relates to a novel basic esters
of benzoic acids and of 2-thiophencarboxylic acids, their
pharmaceutically acceptable salts with acids, to processes for
their preparatlon and to a pharmaceutical composition, containing
these novel esters.

Thus, the present invention provides novel compounds
which e.g. may be used as agents in local anaesthesia, and which
show a lower toxicity and an improved effectiveness over conven-
tional compounds.

The present invention also provid~s processes for
preparing the novel compounds which are easy to carry out and
which are economical.
According to the present invention there are provided
novel basic esters having the formula I

~ ,Il 2--CI~ 2 3
wherein R is a group of the formulae
1~l
~$
~


1 11
l~l s ~
wherein Rl is hydrogen or Cl-C4 alkyl, and R2 is Cl-C4 alkyl,
halogen, a C1-C4 alkoxy, Cl-C4 alkylthio, nitro, amino or a Cl-C4
alkylamino, Rl and R2 being the same or different, and R3 is a




~.

basic group selected from di(Cl-C4) alkylamino or a 6-membered
nitrogen containlng aromatic heterocyclic group which may contain
a further oxygen atom, and their pharmacologlcally useful salts
with acids.





~2~

The first process of this invention for preparing the
ncvel basic esters of formula I

R-~-O-CH2-CH2-R3 (I)

wherein R and R3 are defined above, and their pharmacologically
useful salts, is characterized in that benzoic acids or
thiophencarboxylic acids or their acid halides of the formulae
1 . Rl

~ - COR' alld ~ COR'

- J~2
wherein R' is a hydroxyl group or halogen, and Rl and R2 are
defined above, are reacted with an alcohol of formula II

Hoo-cH2-cH2-R3 (II)
wherein R3 is defined above, and that the obtained compounds
occasionally are transformed into their pharmacologically useful
salts.

The second process of this inventi.on for preparing the
novel basic esters of formula I

o
R-~-o-c~2-cH2-R3 (I)
wherein R and R3 are defined above, and their pharmacologically
useful salts, is characterized ln that salts of benzoi.c acids or
thiophencarboxylic acids of the formulae




~1



- COOI~I and l ~ i
~ ' COO;~I
~2
wherein M is a metal salt, and Rl and R2 are defined above, are
reacted with a halide of formula III

Hal-cH2-c~2-R3 ~III)
wherein ~Ial is a halogen atom, and R3 is defined above, and that
the obtained compounds occasionally are transformed into their
pharmacologically useful salts.

The compounds of the general formula I, wherein R2 is
amino, may be prepared by reducing the nitro compounds.

Both processes of this invention may also be realized
in the presence of at least ona solvent. Occasionally also cata-
lysts may be used. Somebody skilled in the art may easily deter-
mine the suitable reactlon temperatures and reaction times. Usu-
ally one works at standard pressure, whereby also excess pressure
and underpressure ~vacuum) are not excluded.

The administration of the novel compounds of formula I
according to this invention is realized in an usual way, as this
is known in the art for the known compounds,

The preferred embodimen-ts are illustrated in the set of
Examples, wherein also some novel starting materials and interme-
diates are described.





A. Exam~les for benzoic acid esters

Example 1

To a solution of sodium me-thylate, prepared of 2.34 g
(o.l mol) sodiurn in 100 ml absolute ethanol, are added 13.6 g
(o.l mol) 2-methylbenzoic acid and then 15 g (O.ll mol) N-(2-
chloroethyl)-piperidine are added slowly drop by drop. The mix-
ture ~as stirred and heated for 5 hours. After cooling, the pre-
cipitated sodium chloride was filtered with suction and then
washed with ethanol. The filtrate was evaporated in the vacuum
of a water jet pump, the residue was diluted with water and
extracted with ether. The base was extracted with diluted
hydrochloric acid. The acidic solution was made alkaline and was
extracted with ether. After the evaporation of the ether the
base was reacted with etheric hydrochloric acid lnto the
hydrochloride of the 2-methyl-benzoic acid-2-piperidino ethyl
ester. Mp. 164-165C.

ExamPle 2
In the same way as described in Example 1 the
hydrochloride of 2,6-dlmethylbenzoic acid-2-piperidino-ethyl
ester having an mp. 211-213C was obtained, when 26,-dimethyl-
benzoic acid is used instead of 2-methyl-benzoic acid.

Example 3

To a solution of 805 mg (0.035 mol~ sodium in 40 rnl
absolute ethanol are added 5.4 g ~0.035 mol) 2-fluoro-6-methyl-
benzoic acid, and then 6.1 g (0.045 mol) 2-diethyl-amino-
ethylchloride are added drop by drop, and this mixture is
reacted, as described in Example 1, to yield the hydrochloride of
2-fluoro-6-methyl-benzoic acid-2-diethyl-aminoethyl ester having
an mp. of 136.7.

- 5 -
`'.~

The starting material was obtained as follows:

18.75 g (0.1 mol) of 2-amino-6-methyl-benzoic acid-
hydrochloride are diazotized in 55 ml water and 9 ml concentrated
hydrochloric acid with sodium nitrite, and at a temperature of
-5C 50 ml hexafluorophosphoric acid are added. The precipitated
salt was filtered with suction and decomposed in xylene at a tem-
perature of 125C. After cooling, the acid is extracted in a
sodium carbonate solution, acidified and extracted in ether.
After dryiny and evaporating the e-ther, the substance contains as
a by-product 2-hydroxy-6-methyl-benzoic acid. After the esteri-
fication to the ethyl ester, the 2-hydroxy-6-methyl-benzoic acid
ester is extracted in sodium carhonate solution, the 2-fluoro-6-
methyl-benzoic acid-ethyl ester is distilled and saponified with
alcoholic potassium hydroxide. Mp. 124.6~.
Exam~le 4

As described in Example 3, the hydrochloride of 2-
bromo-6-methyl-benzoic acid-2-diethylamino-ethyl ester is pre-
pared from 2-bromo-6-methyl-benzoic acid. Mp. 183.5-18~.5.

Example_5

AS described in Example 3, the hydrochloride of 2-iodo-
6-methyl-benzoic acid-2-diethylamino-ethyl ester is prepared from
the sodium salt of 2-iodo-6-methyl-benzoic acid and 2-diethy-
lamino-ethylchloride and etheric hydrochloric acid. Mp. 192.8.

Exam~le 6
As described in Example 1, the hydrochloride of 2-
ethoxy-6-methyl-benzoic acid-2-diethylamino-ethyl ester is pre-
pared from 2-ethoxy-6-methyl-benzoic acid and 2-diethylamino-
ethylchloride. Mp. 125-127.

~2~

Example 7

When using N--(2-chloroethyl)-piperidine instead of 2-
diethylamino-ethylchloride, then, as described in Example 6, the
hydrochloride of 2-ethoxy-6-methyl-benzoic acid-2-piperidino-
ethyl ester is obtained. Mp. 154.6.

The 2-ethoxy-6-methyl-benzoic acid is synthesized in a
two-step synthesis of 2-chloro-6-methyl-1-benzonitrile.

2-ethoxy-6-methyl-benzonitri]e:

To a sodium methylate solution, prepared of 5.3 g
sodium in 75 ml absolute ethanol, are added 20 g (0.132 mol) 2-

chloro-6-methyl-benzonitrile and this mixture is heated in an
autoclave having a glass insertion for 40 hours at a temperature
of 130. After cooling the precipitated sodium salt is flltered
with suction, the filtrate is evaporated in the vacuum of the
water ~et pump, and the residue is dilute with ether. After
washi.ng, drying and evaporating the ether, a produce having an
mp. of 36-37.5 is obt,ained.

2-ethoxy-6-methyl-benzoic acid:

The nitrile is saponified either in ethanolic potassium
hydroxide under pressure or in glycerine at a temperature of
210C. Mp. 86-38.

_xamPle 8

When 2-ethyl-thio-6-methyl-benzoic acid is used instead
of 2-ethoxy-6-methyl-benzoic acid, then, as in Example 7, the
hydrochloride of 2-ethylthio-6-methyl-benzoic acid-2-diethy-
lamino-ethyl ester is obtained. Mp. 104.3.


Example 8a

When 2.3 g ~0.02 mol) fumaric acid in ethanol are added
to 6 g (0.02 mol~ base of 2-ethylthio-5-methyl-benzoic acid-2-
diethylamino-ethyl ester in ether, then the fumarate crystal-
lizes. Mp. 116.4.

Ex amPl e 9

As in Example 1, the hydrochloride of 2-methyl-6-nitro-
benzoic acid-2-diethylamino-ethyl ester is prepared from the
sodium salt of 2-methyl-6-nitro-benzoic acid, 2-diethylamino-
ethylchloride and etheric hydrochloric acid. Mp. 159-160.5.

Exam~le 10
~ s in Example 1, the hydrochloride of 2-methyl-6-nitro-
benzoic acid-2-piperidino-ethyl ester is prepared from 2-methyl-
6-nitro-benzoic acid. Mp. 181.6.

Example 11

As in Example 10, the hydrochloride of 2-methyl-6-
nitro-benzoic acid-2-morpholino-ethyl ester is prepared when 4-

(2-chloroethyl)-morpholine is used instead of N-(2-chloroethyl)-
piperidine. ~p. 186.9.

Example 12

.
As described in Example 1, the dihydrochloride of 2-
ethylamino-6-methyl-benzoic acid-2-diethylaminoethyl ester is
prepared from 2-ethylamino-6-methyl-benzoic acid, 2-diethylamino-
ethylchloride and etheric hydrochloric acid. Mp. 129.2.



Example 13

AS described ln Example 1, 2-butylamino-6-methyl-ben-
zoic acid and 2-diethyl-amino-ethylchloride are reacted to the
base (2-butylamino-6-methyl-benzoic acid-2-diethylamino-ethyl
ester). When an eg~limolar amount fumaric acid, as described in
Example 8a, is added to the base, then the fumarate having an mp.
of 99.7 is obtained.

The starting materials are prepared as follows:
The mixture of 10.5 g (0.058 mol) 2-amino-6-methyl-ben-
zoic acid-ethyl ester in 87 ml benzene and 14.5 ml acetic acid
and 1~.5 g zinc powder are heated to reflux temperature. Then
6.6 g acetaldehyde in 14.5 ml benzene are added slowly drop by
drop, and the mixture is heated for 2.5 hours under reflux.
After cooling, the mixture is filtered with suction, washed with
benzene, and the filtrate is made alkaline. The benzene layer is
separated, the al~aline aqueous solution is extracted with ben-
zene, the combined benzene layers are washed and dried, and after
the evaporation of the benzene the 2-ethylamino-6-methyl-benzoic
acid-ethyl ester is distilled. Bp. 136-139/min.

~.1 g (0.02 mol) of the ethyl ester in 50 ml ethanol
are saponified with 3.25 g potassium hydroxide in 21.5 ml water
by refluxing for 8 hours. The ethanol is evaporated, to the
residue water is added, the neutral compounds, which may be pre-
sen-t, are extracted with ether, the aqueous solution is acidified
to a pH of 6.5 and extracted with ether. After washing, drying
and evaporating the ether, 2-ethylamino-6-methyl-benzoic acid is
obtained. Mp. 97 . 6.

When butyraldehyde is used instead of acetaldehyde,
then as described above, 2-butylamino-6-methyl-benzoic acid-ethyl
ester is obtained. Bp. 156-158/0.65 mm.


~S

After saponification, 2-butylamino-6-methyl-benzoic
acid is obtained. Mp. 87.9.

Example 14




To 25.5 g (0.92 mol) 2-methyl-6-nitro-benzoic acid-2-
diethylamino-ethyl ester in 500 ml concentrated hydrochloric acid
are added during one hour 100 g tin (II)-chloride, and then the
mixture is heated for one hour on the boiling water bath. After
cooling, the mixture is made alkaline with 35 percent sodium
hydroxide and extracted with ether. After washing the etherical
solution, drying and evaporating the ether, the base is reacted
with etheric hydrogen chloride in the dihydrochloride of 2-amino-
6-methyl-benzoic acid-2-diethylamino-ethyl-ester. Mp. 186-188.

Example 15

~ s described in Example 14, the dihydrochloride of 2-
amino-6-methyl-benzoic acid-N-(2-piperidino)-ethyl ester is pre-
pared, when 2-methyl-6-nitro-benzoic acid-N-(2-piperidino)-ethyl
ester ls used. Mp. 199.8.

B. Examples for 2-thiophencarboxvlic acid esters

Example 1
In the same way as with the benzoic acid esters the
hydrochloride of 3-methylthiophen-2-carboxylic acid-2-diethy-
lamino-ethyl ester is prepared from the sodium sal-t of 3-
methylthiophen-2-carboxylic acid, 2-diethylaminoethylchloride and
etheric hydrochloric acid. Mp. 145.7.




-- 10 --


Example 2

~s described in Example 1, the hydrochloride of 5-
methylthiophen-2-carboxylic acid-2-diethylamino-ethyl ester is
prepared, Mp. 145.7, when 5-methylthiophen-2-carboxylic acid is
used.




- 11 -

Representative Drawing

Sorry, the representative drawing for patent document number 1244020 was not found.

Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date 1988-11-01
(22) Filed 1983-08-26
(45) Issued 1988-11-01
Expired 2005-11-01

Abandonment History

There is no abandonment history.

Payment History

Fee Type Anniversary Year Due Date Amount Paid Paid Date
Application Fee $0.00 1983-08-26
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
PHARMATON S.A.
Past Owners on Record
None
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Description 1993-10-01 11 333
Drawings 1993-10-01 1 13
Claims 1993-10-01 11 254
Abstract 1993-10-01 1 21
Cover Page 1993-10-01 1 21